Searchable abstracts of presentations at key conferences in endocrinology
Endocrine Abstracts (2020) 70 EP74 | DOI: 10.1530/endoabs.70.EP74

ECE2020 ePoster Presentations Bone and Calcium (65 abstracts)

Clinical case: Complicated differential diagnosis between postsurgical and functional hypoparathyroidism.

Elena Kovaleva , Anna Eremkina , Julia Krupinova & Natalia Mokrysheva


Parathyroid Glands Pathology Department, Endocrinology Research Centre, Moscow, Russian Federation


Objective: Postsurgical hypoparathyroidism (HypoPT) is the most common etiology of disease and often occurs after thyroid surgery. However, the differential diagnosis between different forms of HypoPT in some cases remains a challenge. We present the clinical case of postsurgical and functional HypoPT combination.

Case description: A 44-year-old female was referred to the Endocrinology Research Centre. She underwent total thyroidectomy for follicular adenoma performed in 2009. Hypoparathyroidism developed after surgery, so calcium carbonate 1000 mg/day and calcitriol 0.5–1 µg/day were prescribed. She continued this therapy for 2 years and then stopped in 2011. There were no clinical symptoms of hypocalcemia. Laboratory tests revealed albumin-corrected calcium level within 2.11–2.25 mmol/l (normal value 2.1–2.55) and PTH 16.7 pg/ml (15–65). Since 2019 her condition deteriorated with seizures, muscle cramps and paresthesia recurrence. She also had a history of stomach ulcer and therapy with proton pomp inhibitors over last months. Laboratory examination showed a decrease of PTH level less 3.0 pg/ml, hypocalcaemia (1.8 mmol/l), hyperphosphatemia (1.9 mmol/l (0.74–1.52) as well as hypomagnesemia 0.6 mmol/l (0.7–1.05). 25(OH)D blood test was normal – 37 ng/ml (30–100). Сalcium carbonate 1000 mg/day and calcitriol 1 mcg/day were immediately prescribed. Also she was started on magnesium supplements about 400–600 mg/day per os to control the hypomagnesaemia. After 6 months, lab. Test revealed normal magnesium (0.83 mmol/l), target calcium levels (2.32 mmol/l) and increased PTH to 24 pg/ml. There was complete symptom resolution. Step-by step the doses of calcium carbonate and calcitriol were reduced. Patient is currently receiving cholecalciferol in daily dose of 2000 IU. Her physical and laboratory examination remain normal.

Conclusion: Hypomagnesemia is recognized as a cause of hypoparathyroidism due to impaired parathyroid hormone secretion, with resultant hypocalcemia. This case demonstrates the importance of looking for all associated electrolyte abnormalities in patients with HypoPT.

Volume 70

22nd European Congress of Endocrinology

Online
05 Sep 2020 - 09 Sep 2020

European Society of Endocrinology 

Browse other volumes

Article tools

My recent searches

No recent searches.